Nova (NasdaqGS:NVMI) drew fresh attention after reports of broader global adoption of its metrology tools in advanced packaging and AI driven chip production at major foundries, with investors also watching for upcoming quarterly earnings.

Over the past month the stock has come under pressure, with a 30 day share price return down 22.23% and a 90 day share price return down 20.95%. However, Nova still shows stronger longer term momentum with a 1 year total shareholder return of 48.31% and a 5 year total shareholder return of 286.39%.

If Nova's recent swings have you thinking about other opportunities in chip and AI related hardware, this could be a useful moment to scan 57 AI infrastructure stocks

Novo's share price has swung sharply, even as interest in its AI related metrology tools remains strong. Has the recent pullback reset expectations enough, or has most of the easy upside already been priced in ahead of valuation work?

Most Popular Narrative: 35% Undervalued

Nova's most followed narrative places fair value at $597.63, well above the last close at $390.87. That gap is built on detailed earnings and revenue projections that stretch out several years.

The accelerating complexity of semiconductor devices, driven by AI, larger die sizes, advanced nodes, and heterogeneous packaging, continues to fuel demand for Nova's advanced metrology solutions across both logic/foundry and memory segments, which is poised to lift long-term revenue growth as global digitization trends expand.

Read the complete narrative. Read the complete narrative.

Want to understand why this fair value sits well above today's price? The narrative leans heavily on compounding revenue gains, higher margins and a rich earnings multiple. Curious which of those inputs really carries the model? The full narrative spells out the assumptions line by line.

Result: Fair Value of $597.63 (UNDERVALUED)

However, Nova's reliance on a handful of advanced node customers and the execution risk around new platforms like ELIPSON and METRION could quickly challenge this upbeat narrative.

Another View On Nova's Valuation

The popular narrative has Nova looking about 35% undervalued against a fair value of $597.63. The SWS DCF model tells a very different story. On that framework, Nova at $390.87 sits well above an estimated future cash flow value of $131.08, which screens as overvalued instead.

This gap between an optimistic narrative and a much lower cash flow estimate raises a practical question for investors. Which set of assumptions feels closer to how Nova will actually convert its current growth into long term cash generation, and how much valuation risk are you comfortable taking on that difference.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Nova for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 55 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Feeling unsure which side of the Nova story carries more weight right now? Move quickly, review both the cautious and optimistic factors, then weigh up the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Nova?

If you want to keep your edge after reviewing Nova, this is the moment to scan other opportunities using the Simply Wall St screener.

• Spot companies that look mispriced on quality and valuation by checking the 55 high quality undervalued stocks.
• Zero in on potential income anchors for your portfolio with the 9 dividend fortresses.
• Lock in peace of mind by reviewing the 81 resilient stocks with low risk scores before the next bout of volatility catches you off guard.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.